Research

More Research Stories

OHSU Spinoff Completes Initial Public Offering On NASDAQ

May 30, 2007
A spinoff company based in part on the findings of Oregon Health & Science University's obesity research has completed its initial public offering. Recently, Orexigen Therapeutics Inc. offered 8.05 million shares of common stock at the initial public ...

First NW Patient To Receive OHSU/VAMC-Invented Ms Drug

May 21, 2007
A 55-year-old Montesano, Wash. woman will be the first person in the Northwest to be treated with a promising new multiple sclerosis drug developed entirely at Oregon Health & Science University and the Portland Veterans Affairs Medical Center. Anne ...

OHSU Physician Leading Study Of Omega-3 For Alzheimer's

May 21, 2007
An Oregon Health & Science University neurologist is directing a national study examining whether omega-3 fatty acids, found in fish, can lower the risk of Alzheimer's disease. Joseph Quinn, M.D., associate professor of neurology, OHSU School of ...

Personalized Medicine' Goal of Human Genetics Initiative

April 25, 2007
A woman sees her doctor with a severe cough. Diagnosed with pneumonia, she's put on a standard antibiotics regimen. If she has a negative reaction to the drugs, the treatment is stopped. But the long-term effects of that negative reaction could be ...

De-activating Protein May Protect Nerve Fibers In MS

April 23, 2007
Oregon Health & Science University neuroscientists are eyeing a protein as a potential therapeutic target for multiple sclerosis because de-activating it protects nerve fibers from damage. OHSU researchers, working with colleagues at the Portland ...

OHSU Lab Finds Meth Receptor That Could Lead To Therapy

April 18, 2007
A recently discovered signaling system in the brain has just been shown to be turned on by methamphetamine, an Oregon Health & Science University study found. The signaling system could soon become a target for therapies aiming to reverse meth’s ...
See more stories